Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
- 20 February 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 13 (4), 393-400
- https://doi.org/10.1093/neuonc/noq204
Abstract
Concomitant radiation therapy (RT) and temozolomide (TMZ) therapy after surgery is the standard treatment for glioblastoma multiforme (GBM). Radiation and chemotherapy can affect the immune system with implications on subsequent immune therapy. Therefore, we examined the phenotype and function of peripheral blood mononuclear cells in 25 patients with GBM prior to and 4 weeks after treatment with RT-TMZ using multicolor flow cytometry, as well as in vitro CD4+ regulatory T cell (Treg) suppressor and dendritic cell maturation assays. RT-TMZ induced significant lymphopenia, with a decrease in total CD4+ T cells, but did not significantly change monocyte counts. The proportion of functional Treg cells increased after treatment, whereas their absolute numbers remained stable. There was also a measurable decrease in the proportion of CD8+CD56+ and absolute number of CD3−CD56+ effector cells. Posttherapy monocytes retained the ability to mature into dendritic cells. Treatment with RT-TMZ is associated with changes in regulatory and effector peripheral blood mononuclear cells that tilt the balance towards an immune suppressive state. This shift can affect the outcome of immune therapy following RT-TMZ treatment and should be considered in the design of future combination therapy regimens.Keywords
This publication has 28 references indexed in Scilit:
- Effects of Concomitant Temozolomide and Radiation Therapies on WT1-specific T-cells in Malignant GliomaJapanese Journal of Clinical Oncology, 2010
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patientsNeuro-Oncology, 2009
- Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma MultiformeClinical Cancer Research, 2008
- Change in expression of MGMT during maturation of human monocytes into dendritic cellsDNA Repair, 2007
- Human regulatory T cells and their role in autoimmune diseaseImmunological Reviews, 2006
- Mechanisms of malignant glioma immune resistance and sources of immunosuppression2006
- Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory statusLeukemia Research, 2005
- Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor MicroenvironmentClinical Cancer Research, 2005
- Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infectionInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Selective CD4+ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic ImplicationsJournal of Clinical Oncology, 2004